Skip to main content
SENORES PHARMACEUTICALS LIMITED logo

SENORES PHARMACEUTICALS LIMITED — Investor Relations & Filings

Ticker · SENORES ISIN · INE0RB801010 LEI · 984500FQ4CDFAFBBD763 BSE.NS Manufacturing
Open in API
Filings indexed 182 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country IN India
Listing BSE.NS SENORES

About SENORES PHARMACEUTICALS LIMITED

https://senorespharma.com/

Senores Pharmaceuticals Limited is an R&D-driven pharmaceutical organization specializing in the development, manufacturing, and commercialization of complex generic formulations. The company focuses on niche therapeutic segments and specialty products, including oral solids, liquids, and topicals, with a significant emphasis on complex injectables and ophthalmic solutions. Senores leverages its advanced research capabilities to address unmet medical needs in highly regulated global markets, particularly the United States. Its business model integrates end-to-end capabilities from product identification and formulation development to regulatory filing and global distribution. The company is committed to delivering high-quality, affordable healthcare solutions through strategic partnerships and a robust pipeline of value-added medicines designed to improve patient outcomes in specialized clinical areas.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 82% confidence The document is an exchange filing under SEBI LODR Regulation 30, notifying the stock exchanges of the schedule of analyst/institutional investor meetings. It does not contain financial results (ER/IR), audit content (AR), or investor presentation materials (IP), nor is it a proxy, dividend notice, or board change. It is a routine regulatory disclosure of material events under continuous listing obligations, fitting the fallback category of general regulatory announcements.
2026-05-22 English
Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on May 28, 2026.
Regulatory Filings Classification · 85% confidence The document is a stock exchange disclosure under SEBI LODR (Regulation 30) announcing the schedule of analyst/institutional investor meetings. It contains no financial statements or substantive report content, but is a compliance/regulatory filing. Therefore, it fits the Regulatory Filings category (RNS).
2026-05-22 English
Senores Pharmaceuticals Limited has informed the Exchange regarding submission of Annual Secretarial Compliance Report for financial year ended March 31, 2026
Regulatory Filings Classification · 88% confidence The document is an Annual Secretarial Compliance Report submitted by the Company Secretary to the stock exchanges under SEBI LODR Regulations, 2015. It is primarily an attestation/certification letter verifying compliance with SEBI regulations rather than the company’s financial or governance report itself. Under the provided rules, officer certifications and compliance certificates should be classified as Regulatory Filings (RNS).
2026-05-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 92% confidence The document is a formal intimation to stock exchanges under SEBI LODR Regulation 30, notifying the schedule of analyst/institutional investor meetings. It contains no financial statements, is not a presentation itself, and is a compliance announcement. This fits the fallback category for general regulatory filings (RNS).
2026-05-20 English
Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on May 25, 2026.
Regulatory Filings Classification · 80% confidence The document is a notification to stock exchanges under SEBI LODR Regulation 30 regarding the schedule of analyst/institutional investor meetings. It is a compliance/regulatory announcement rather than a financial report, presentation, or any other specific category. Therefore, it falls under the generic “Regulatory Filings” category.
2026-05-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call for Q4 FY26 of Senores Pharmaceuticals Limited. It includes management's opening remarks, financial performance highlights, segmental performance, recent acquisitions, and outlook for the next fiscal year. The text references the earnings call date, financial results for the quarter and fiscal year, and includes a Q&A session format typical of earnings call transcripts. There is no indication that this is a brief announcement or a report publication notice; rather, it is the full transcript of the call. Therefore, the document fits the definition of a Call Transcript (CT).
2026-05-19 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.